MedPath

A clinical study on Parsiaoshan in treatment of kidney stone

Phase 2
Conditions
Health Condition 1: N200- Calculus of kidney
Registration Number
CTRI/2021/03/032231
Lead Sponsor
Central Council of Unani Medicine New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

• Clinically/Radiologically diagnosed patients of Hasah al-Kulya (Nephrolithiasis) from size 5 to 8 mm.

• Patients irrespective of gender.

• Patients in the age group of 20 to 60 years.

• Patients who have agreed to sign the informed consent form and follow the protocol.

Exclusion Criteria

• Pregnant and Lactating Women.

• Patients below and above the age of 20 and 60 years respectively.

• Diabetes Mellitus.

• Hydronephrosis.

• Poorly controlled Hypertension.

• Significant Liver or Renal dysfunction.

• Cardiovascular disease.

• Unwillingness or inability to fulfill the protocol.

• A medical condition that in the investigatorâ??s opinion would interfere the treatment, safety, or adherence to the protocol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relief in signs and symptoms of nephrolithiasisTimepoint: 60 days
Secondary Outcome Measures
NameTimeMethod
Haematological, radiological and Biochemical assessmentTimepoint: 60 days
© Copyright 2025. All Rights Reserved by MedPath